Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-08-25

    Virtual Booth

    An Enquiry

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-08-25

    Virtual Booth

    An Enquiry

    Menu

    Lenacapavir

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 39,348Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 5GILEAD SCIENCES INC

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    GILEAD SCIENCES INC

    U.S.A
    Peptide Process CMC
    Not Confirmed
    arrow

    GILEAD SCIENCES INC

    U.S.A
    arrow
    Peptide Process CMC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    LENACAPAVIR SODIUM

    Brand Name : SUNLENCA

    Dosage Form : SOLUTION;SUBCUTANEOUS

    Dosage Strength : EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML)

    Approval Date : 2022-12-22

    Application Number : 215973

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    GILEAD SCIENCES INC

    U.S.A
    Peptide Process CMC
    Not Confirmed
    arrow

    GILEAD SCIENCES INC

    U.S.A
    arrow
    Peptide Process CMC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    LENACAPAVIR SODIUM

    Brand Name : SUNLENCA

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 300MG BASE

    Approval Date : 2022-12-22

    Application Number : 215974

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    GILEAD SCIENCES INC

    U.S.A
    Peptide Process CMC
    Not Confirmed
    arrow

    GILEAD SCIENCES INC

    U.S.A
    arrow
    Peptide Process CMC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    LENACAPAVIR SODIUM

    Brand Name : YEZTUGO

    Dosage Form : SOLUTION;SUBCUTANEOUS

    Dosage Strength : EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML)

    Approval Date : 2025-06-18

    Application Number : 220018

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    GILEAD SCIENCES INC

    U.S.A
    Peptide Process CMC
    Not Confirmed
    arrow

    GILEAD SCIENCES INC

    U.S.A
    arrow
    Peptide Process CMC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD :

    TE Code :

    LENACAPAVIR

    Brand Name : YEZTUGO

    Dosage Form : SOLUTION;SUBCUTANEOUS

    Dosage Strength : 463.5MG/1.5ML(309MG/ML)

    Approval Date :

    Application Number : 220018

    RX/OTC/DISCN :

    RLD :

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    GILEAD SCIENCES INC

    U.S.A
    Peptide Process CMC
    Not Confirmed
    arrow

    GILEAD SCIENCES INC

    U.S.A
    arrow
    Peptide Process CMC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    LENACAPAVIR SODIUM

    Brand Name : YEZTUGO

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 300MG BASE

    Approval Date : 2025-06-18

    Application Number : 220020

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF